Xerimis is pleased to announce the appointment of Simon Magness as Operations Manager for Xerimis’ new facility in Theale, United Kingdom. Simon joins Xerimis to lead the Operations group and mold Xerimis LTD into the premier clinical packaging and distribution vendor within Europe.
Simon comes to Xerimis with 10 years of direct clinical supply experience and a PhD, Analytical Organic Chemistry. He has extensive experience working for leading pharma companies including Pfizer, Takeda, and Daiichi Sankyo. He has also managed clinical supply projects as a vendor while working with BAP Pharma.
“I am pleased to announce the addition of Dr. Simon Magness to Xerimis’ leadership team,” said Carol Sue Bernardo, CEO of Xerimis. “Simon has a strong scientific background and extensive experience in Clinical Supplies. His background and previous work experience will support him in his role as Operations Manager and will complement and support the team that is in place already. Simon’s customer focus will be invaluable as we expand our reputation for outstanding service into the European market.”
Xerimis debuted its purpose-built, 13,000-square foot United Kingdom facility in 2016. This is the second location for the privately held, New Jersey-headquartered clinical packaging provider. Located thirty minutes west of Heathrow and within easy access of London, the MHRA-approved space is designed to receive, store, label, package and distribute clinical supplies within the European Union. The facility holds WDA, MIA-IMP, and MS licenses. Three on-site QPs provide services ranging from CTA submission to QP releases of finished, packaged supplies.